- Conditions
- Hyperhidrosis
- Interventions
- WL8713, 6 mg, WL8713, 12 mg, WL8713, 18 mg, WL8713, 24 mg, Placebo
- Drug
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 195 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- San Diego, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–13
of 13
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Primary Focal Hyperhidrosis, Axilla
- Interventions
- DTS-G2 System, DTS System (Sham treatment)
- Device
- Lead sponsor
- Miramar Labs
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 7
- States / cities
- Sacramento, California • San Diego, California • Sunnyvale, California + 4 more
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Sofpironium Bromide Gel, 5%, Sofpironium Bromide Gel, 15%
- Drug
- Lead sponsor
- Botanix Pharmaceuticals
- Industry
- Eligibility
- 9 Years to 65 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 12
- States / cities
- Mobile, Alabama • Rogers, Arkansas • Aventura, Florida + 9 more
- Conditions
- Hyperhidrosis
- Interventions
- Glycopyrronium Topical Wipes
- Drug
- Lead sponsor
- Journey Medical Corporation
- Industry
- Eligibility
- 9 Years and older
- Enrollment
- 564 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 40
- States / cities
- Mobile, Alabama • Rogers, Arkansas • Encinitas, California + 37 more
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- ANT-1403, placebo
- Biological
- Lead sponsor
- Anterios Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013
- U.S. locations
- 9
- States / cities
- Miami, Florida • Pinellas Park, Florida • West Palm Beach, Florida + 6 more
- Conditions
- Hyperhidrosis
- Interventions
- Botulinum toxin type A, Placebo comparator
- Biological
- Lead sponsor
- Revance Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Hyperhidrosis
- Interventions
- Umeclidinium, Vehicle
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Raleigh, North Carolina • Austin, Texas
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Ulthera System treatment
- Device
- Lead sponsor
- Ulthera, Inc
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Ulthera System, Sham treatment
- Device
- Lead sponsor
- Ulthera, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 6
- States / cities
- Roseville, California • Aventura, Florida • Chicago, Illinois + 3 more
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Roll-In Cohort: Single Application of N-SWEAT Patch, Randomized Cohort: Single Application of N-SWEAT Patch, Randomized Cohort: Single Application of Sham Patch
- Device
- Lead sponsor
- Candesant Biomedical, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 9
- States / cities
- Encinitas, California • Fremont, California • Rockville, Maryland + 6 more
- Conditions
- Hyperhidrosis
- Interventions
- Vehicle, ANT-1207
- Biological
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 145 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 19
- States / cities
- Hialeah, Florida • Miami, Florida • Pinellas Park, Florida + 16 more
- Conditions
- Hyperhidrosis Primary Focal Axilla
- Interventions
- Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis.
- Device
- Lead sponsor
- InMode MD Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 3
- States / cities
- New York, New York • Knoxville, Tennessee • Dallas, Texas
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Sofpironium Bromide Gel, 15%
- Drug
- Lead sponsor
- Botanix Pharmaceuticals
- Industry
- Eligibility
- 9 Years to 16 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Rogers, Arkansas